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Abstract
Evidence‐based ulcer care guidelines detail optimal components of care for treatment of ulcers of different etiologies. 
We investigated the impact of providing specific evidence‐based ulcer treatment components on healing outcomes for 
lower limb ulcers (LLU) among veterans in the Pacific Northwest. Components of evidence‐based ulcer care for 
venous, arterial, diabetic foot ulcers/neuropathic ulcers were abstracted from medical records. The outcome was ulcer 
healing. Our analysis assessed the relationship between evidence‐based ulcer care by etiology, components of care 
provided, and healing, while accounting for veteran characteristics. A minority of veterans in all three ulcer‐etiology 
groups received the recommended components of evidence‐based care in at least 80% of visits. The likelihood of 
healing improved when assessment for edema and infection were performed on at least 80% of visits (hazard ratio 
[HR]=3.20, p=0.009 and HR=3.54, p=0.006, respectively) in patients with venous ulcers. There was no significant 
association between frequency of care components provided and healing among patients with arterial ulcers. Among 
patients with diabetic/neuropathic ulcers, the chance of healing increased 2.5‐fold when debridement was performed 
at 80% of visits (p=0.03), and doubled when ischemia was assessed at the first visit (p=0.045). Veterans in the Pacific 
Northwest did not uniformly receive evidence‐based ulcer care. Not all evidence‐based ulcer care components were 
significantly associated with healing. At a minimum, clinicians need to address components of ulcer care associated 
with improved ulcer healing. 
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ABSTRACT 
Evidence‐based ulcer care guidelines detail optimal components of care for treatment of ulcers of 
different etiologies. We investigated the impact of providing specific evidence‐based ulcer 
treatment components on healing outcomes for lower limb ulcers (LLU) among veterans in the 
Pacific Northwest. Components of evidence‐based ulcer care for venous, arterial, diabetic foot 
ulcers/neuropathic ulcers were abstracted from medical records. The outcome was ulcer healing. 
Our analysis assessed the relationship between evidence‐based ulcer care by etiology, 
components of care provided, and healing, while accounting for veteran characteristics. A 
minority of veterans in all three ulcer‐etiology groups received the recommended components of 
evidence‐based care in at least 80% of visits. The likelihood of healing improved when 
assessment for edema and infection were performed on at least 80% of visits (hazard ratio 
[HR] = 3.20, p = 0.009 and HR = 3.54, p = 0.006, respectively) in patients with venous ulcers. 
There was no significant association between frequency of care components provided and 
healing among patients with arterial ulcers. Among patients with diabetic/neuropathic ulcers, the 
chance of healing increased 2.5‐fold when debridement was performed at 80% of visits 
(p = 0.03), and doubled when ischemia was assessed at the first visit (p = 0.045). Veterans in the 
Pacific Northwest did not uniformly receive evidence‐based ulcer care. Not all evidence‐based 
ulcer care components were significantly associated with healing. At a minimum, clinicians need 
to address components of ulcer care associated with improved ulcer healing.  
Chronic lower limb ulcers (LLU) occur most commonly as the result of complications of venous 
hypertension, arterial insufficiency, and diabetes. Evidence‐based (EB) guidelines for etiology‐
specific ulcer care exist.1-5 Yet in both specialty and general settings, the delivery of evidence‐
based ulcer care is not uniform. Reasons include the broad clinical spectrum of chronic ulcers, 
variation in diagnosis and treatment, differences in rural‐urban access, poor care coordination 
between generalist and specialist providers caring for the same patient and contributions from 
other medical comorbidities.  
Components of EB ulcer care have been associated with improved wound healing for venous, arterial, 
and DFU/neuropathic ulcers (Table 1). Evidence‐based ulcer care is associated with improvements in 
chronic venous ulcer outcomes, which account for over 70% of all LLUs.27 A study by Olson and 
associates assessed the impact of EB ulcer care on venous ulcer healing and reported that the likelihood 
of ulcer healing among veterans increased when compression therapy, sharp debridement, and moist 
wound healing were all provided in at least 80% of visits (RR = 2.52; 95% confidence interval [CI]: 1.53–
4.16).6 Compression therapy and moist wound healing both independently increased the likelihood of 
healing when performed at ≥80% of visits, however debridement alone was not significantly associated 
with venous ulcer healing.6 
Table 1. Chronic ulcer definition and evidence‐based ulcer care components 
Ulcer etiology 
and evidence‐
based 
references 
Evidence‐based ulcer care components Ulcer etiology definitions 
Venous 
 1− 3, 6-13 
1‐ Compression therapy: edema control 
could be achieved through the use of 
compression stockings or dressings or by 
elevating the lower extremities  
Ulcers due to venous incompetence 
most commonly occur above the 
medial or lateral malleoli11 
 2− 3, 8, 12-
15 
2‐ Moist wound healing: application of 
dressing that maintains moist wound 
environment. All major moist dressings 
were considered, for example Duoderm, 
Hydrosorb, Aquaphore, hydrocolloid and 
Alginate dressing, Tegaderm,  
 3− 3, 16, 17 
Allevyn, Vaseline gauze, etc. 
 3‐ Sharp debridement: remove all 
necrotic or devitalized tissue by surgical 
and mechanical means  
Arterial 
 1 and 2− 1, 
18-21 
1‐ Assess ischemia (palpable pedal 
pulses, ABI > 0.8, normal Doppler 
waveform, normal color duplex 
ultrasound, toe‐brachial index > 0.7)  
Caused by poor perfusion to the lower 
limbs and often affects the toes or 
shin or occurs over pressure points.11 
Findings include absent pedal pulses, 
ABI < 0.9 and/or MRI/ultrasound 
evidence of arterial blockage  
2‐ Evaluation for revascularization: in 
this study a vascular surgery encounter 
within 30 days of ulcer onset was 
considered a component of ulcer care  
DFU/Neuropathic 
 1− 2, 18-21 1‐ Assess ischemia (palpable pedal pulses, ABI > 0.8, normal Doppler 
Usually occurs on plantar aspect of 
feet or over pressure points in 
Ulcer etiology 
and evidence‐
based 
references 
Evidence‐based ulcer care components Ulcer etiology definitions 
waveform, normal color duplex 
ultrasound, toe‐brachial index > 0.7)  
patients with diabetes and neurologic 
disorders11 
 2− 2, 4, 22 
2‐ Offloading: crutches, walkers, 
wheelchairs, custom shoes, depth shoes, 
shoe modifications, custom inserts, 
custom relief orthotic walkers (CROW), 
diabetic boots, forefoot and heel relief 
shoes, and total contact casts  
 3− 2, 14 3‐ Moist wound healing: see above for venous ulcers 
 4− 2, 16, 23, 
24 
4‐ Sharp debridement: see above for 
venous ulcers 
All chronic 
ulcers 1-3, 25, 
26 
Infection assessment: ulcer examination 
for signs of invasive bacterial infection of 
soft tissue or bone  
 
 
Arterial insufficiency, the second most common cause of LLUs, accounts for 10–30% of all 
chronic LLUs.27 Diabetic ulcers comprising 15–25% of LLUs,27 have the worst prognosis and 
the highest amputation rate.5, 28 As the prevalence of diabetes is higher among veterans (24%) 
than the general population (8%), they experience higher rates of diabetes‐related ulcers and 
amputations.29 
In spite of existing ulcer guidelines, there is still a significant practice gap in the evidence‐based 
diagnosis and treatment of these ulcers.30 The purpose of this study is to investigate the 
frequency that components of EB ulcer care are performed in rural and urban VA settings within 
the Northwest Health Network (VISN 20) of the U.S. Department of Veterans Affairs (VA) 
Health System, and their impact on LLU outcomes among veterans. We hypothesized that 
veterans receiving EB ulcer care would experience improved ulcer outcomes.  
METHODS 
Subject selection 
This study, a retrospective medical records review, was conducted in VA's VISN 20, which 
included 8 medical centers and 23 community based outpatient clinics (CBOCs). This project 
was approved by VA Puget Sound Health Care System Institutional Review Board. A set of 
high‐probability ICD‐9 codes (n = 46), based on previous studies, was used to identify potential 
subjects with at least one incident LLU between October 1, 2006 and September 30, 2007.31 The 
parent study, examining differences between rural and urban veterans, screened a randomized list 
of potential patients until 160 rural and 160 urban veterans who met inclusion criteria were 
identified. All 320 veterans had a chronic LLU, defined as an open wound that did not heal 
within 30 days of the first VA treatment visit. Ulcers were associated with at least two VA 
encounters, at least one of which had to be outpatient. Veterans who died within 30 days of ulcer 
onset were excluded.  
Following identification of the 320 patients in the parent study, ulcer etiology was determined by 
reviewing all progress notes and diagnostic tests relating to ulcer care. Ulcers with venous, arterial, and 
DFU/neuropathic etiology were included; all other ulcers (pressure ulcers [n = 31], infection only 
[n = 32], dermatological conditions, trauma and other [n = 33]) were excluded from this study. Figure 1 
illustrates the algorithm used to categorize arterial, venous, and DFU/neuropathic ulcers. The first 
branch point was based on peripheral arterial status. Both ankle brachial index (ABI) < 0.8 and arterial 
imaging studies were used to assess arterial status. If severe arterial disease was not identified, ulcers 
were further categorized as venous or DFU/neuropathic. Although most veterans in this study had 
multiple comorbidities, ulcer etiology was determined based on clinical testing and/or specialist 
assessment. For example, a veteran with severe PAD meeting the above peripheral arterial disease 
criteria was classified as having arterial ulcer etiology despite a history of venous disease. Someone with 
diabetes who experienced a new venous ulcer would be classified with venous ulcer etiology. Ulcers 
were classified as having mixed etiology if, based on specialist assessment, more than one etiology 
contributed to the nonhealing ulcer. Foot ulcers in veterans with nondiabetic neuropathy were 
combined with diabetic foot ulcers for analysis as management of purely neuropathic ulcers are not 
separated from DFU in the literature and because there were a small number of this these ulcers. 
 
 
 
Figure 1 
Retrospective ulcer etiology determination using provider progress notes, n = 224. If ABI >1.0 or 
if arteries were incompressible then ABI was not used to classify etiology; in these cases, more 
advanced imaging and/or vascular surgery consult notes including clinical judgment were used to 
classify ulcers.  
Data collection  
We abstracted medical records from the VA's Computerized Patient Record System (CPRS) to 
collect demographic, health‐history, and ulcer care‐related variables from October 1, 2006 to 
September 30, 2007. A chronic ulcer was defined as a wound that did not heal completely after 
receiving medical treatment for 30 days, base on the Centers for Medicare and Medicaid 
Services definition.32 Ulcer related progress notes were reviewed for documentation of ulcer 
care treatment components and ulcer outcomes. The following elements were recorded for every 
visit: provider assessment for ulcer infection, sharp debridement, offloading implementation, 
moist wound healing environment, edema assessment, edema control, LL ischemia assessment, 
presence/absence of LL ischemia, antibiotic prescription for systemic and/or wound infection, 
imaging and surgical procedures, global assessment, and follow‐up planning. The primary 
outcome, healing, was defined as the complete re‐epithelialization of the ulcer with documented 
maintenance of skin integrity for at least 30 days, based on wound care provider chart notes.  
Health history was recorded at baseline (first ulcer treatment visit) based on medical record and 
provider diagnosis. All conditions were classified as present or absent except diabetes which was 
a three‐level variable based on ADA criteria: no diabetes, diabetes and HbA1c ≤7, and diabetes 
and HbA1C levels >7.33 Veterans were classified as “ever” smokers if a progress note said they 
currently smoked or had smoked in the past.  
Rural residence was defined using the VA's classification system, based on United States Census 
Bureau–defined urbanized areas (urban areas are blocks or block groups with a minimum density 
of 1,000 people per square mile and surrounding blocks with a minimum density of 500 people 
per square mile). Any nonurban area was considered rural.34 
Ulcer outcomes 
We followed veterans first ulcer from their initial VA visit up to one year for the following 
outcomes: healed, amputated, died with active ulcer, unresolved ulcer at end of observation 
period, and lost to follow‐up. If an ulcer did not heal within one year of first treatment, the 
outcome was considered “unresolved.” If the ulcer resolution date was not stated in the chart but 
the ulcer was on a healing trajectory (e.g., decreasing size, evidence of granulation), the healed 
date was estimated as the date of the next visit when the ulcer was no longer mentioned, if this 
visit was within 6 months of the preceding ulcer treatment visit, or as the mid‐point of the most 
recent visit and last visit, if more than 6 months elapsed.  
Statistical analysis 
Data management was conducted using SAS 9.2 (Cary, NC) and statistical analyses were 
conducted in STATA 12.1 (College Station, TX). Cox models were used to assess the impact of 
ulcer care components on ulcer healing as the main outcome for ulcers of each etiology. A 
hazard ratio above 1 implies improved chance of healing. A separate Cox model was created for 
each of the three ulcer types. Veterans with mixed etiology were included in analyses for all 
etiology groups to which they were assigned. All models included rural status; age at 
presentation of first study ulcer; smoking status; and history of coronary artery disease (CAD), 
lower limb ulcer, lower limb amputation, and moderate to severe renal disease.  
The Cox model for venous ulcers assessed whether the following EB care components were 
performed in at least 80% of visits: edema assessment, moist wound healing, and infection 
assessment. The model also included a continuous variable documenting the percent of visits 
when edema was present and was treated. As there were too few visits where edema was both 
assessed by the provider and treated, we could not create a separate variable for edema treatment. 
In addition to the common variables noted above, the venous ulcer model was adjusted for 
history of PAD and diabetes presence/control.  
The Cox model for veterans with arterial ulcers included binary indicators of ischemia 
assessment at first visit, if infection was assessed in at least 80% of visits, and whether a vascular 
surgery consult occurred within 30 days of ulcer presentation. The arterial ulcer model also 
included adjustment for diabetes presence/control. We did not adjust for history of PAD in this 
model as we presumed that all veterans with this type of ulcer had underlying arterial disease, 
regardless of prior diagnoses.  
The Cox model for veterans with DFU/neuropathic ulcers included binary indicators of whether 
sharp debridement, moist wound healing, infection assessment, and offloading were performed 
in at least 80% of visits. The model included adjustment for history of PAD and diabetes control. 
We did not adjust for diabetes diagnosis in this model.  
For each model, we tested to see if the proportional hazards assumptions for the Cox model were 
satisfied. We used the Multiple Imputation by Chained Equations (MICE) method to impute missing 
values, specifically: 6 missing BMI, 1 history of lower leg ulcer, and 12 history of smoking values. Factors 
used to predict these values were history of diabetes, PAD, CAD, age at ulcer onset, previous lower limb 
amputation, congestive heart failure, and renal disease. We used 10 simulated datasets to impute the 
data. 
RESULTS 
There were 224 veterans from the parent study with venous, arterial, or DFU/neuropathic ulcer 
etiology and mixed ulcer etiologies who were included in this study: 78 venous, 57 arterial, and 
98 DFU/Neuropathic as shown in Figure 1.  
Table 2 shows most veterans were white males in their mid to late 60s. Health history findings 
across ulcer groups showed a higher prevalence of diabetes and metabolic syndrome and sensory 
neuropathy among those with DFU/neuropathic ulcers; a higher prevalence of PAD, CAD, MI, 
CHF, prior amputation, immobility and smoking in the arterial ulcer group; and a higher 
prevalence of venous insufficiency and BMI > 30 among those with venous ulcers. Table 3 
shows the proportion of veterans with venous, arterial, and DFU/neuropathic ulcers who had a 
history of diabetes as 47%, 70%, and 89%, respectively. Table 3 also shows ulcer outcomes at 12 
months. Among the various ulcer etiologies, diagnosed diabetes was present in 47% with venous 
ulcers, 70% in afterial ulcers and 90% in diabetic and neuropathic ulcers. At 1 year of follow‐up, 
72% of venous ulcers, 53% of arterial ulcers, and 75% of DFU/neuropathic ulcers had healed. 
The highest proportion of amputations occurred in veterans with arterial ulcers (23%) followed 
by veterans with DFU/neuropathic ulcers (15%) and veterans with venous ulcers (1%). The 
highest proportion of deaths was in the arterial ulcer group (12%). After one‐year follow‐up, the 
highest proportion of unhealed ulcers was in the venous ulcer group (18%).  
Table 2. Demographic and health characteristics of veterans with chronic lower limb ulcers in 
VISN 20 from October 1, 2006 to September 30, 2007 (n = 224)  
 
Variable Category 
Veterans 
with 
venous 
ulcer 
(n = 57)a 
Veterans 
with 
arterial 
ulcer 
(n = 78)a 
Veterans with 
DFU/Neuropathic 
ulcer (n = 98)a 
Age at first study ulcer 
presentation Mean – 67 69 64 
Sex,% Male 100 98 99 
Race,% 
White 65 60 67 
African American 3 5 6 
Other/Missing 31 35 27 
Residence, % 
Rural 55 44 48 
Urban 45 56 52 
Medical history 
(condition(s) diagnosed 
before ulcer onset), % 
Metabolic 
syndrome 71 61 82 
Diabetes 47 70 90 
Sensory neuropathy 33 70 85 
Charcot 
neuroarthropathy 0 0 6 
Peripheral arterial 
disease (PAD) 31 95 31 
Venous 
insufficiency 49 18 7 
Hypertension 83 89 85 
Coronary artery 
disease (CAD) 42 60 35 
Variable Category 
Veterans 
with 
venous 
ulcer 
(n = 57)a 
Veterans 
with 
arterial 
ulcer 
(n = 78)a 
Veterans with 
DFU/Neuropathic 
ulcer (n = 98)a 
Myocardial 
infarction (MI) 15 33 13 
Congestive heart 
failure (CHF) 31 37 20 
Cerebrovascular 
disease 10 33 17 
Moderate or severe 
renal disease 19 23 16 
Cancer 10 21 9 
Immobility history 
(current or former) 31 56 26 
Lower limb history, % 
Lower limb surgery 
within 60 days of 
index visit 
0 23 13 
Traumatic lower 
limb injury 20 11 17 
Prior lower limb 
ulcer 68 62 66 
Amputation 10 39 34 
Lifestyle, 
% 
Smoking 
history Current or former 68 82 37 
Body mass 
index (BMI) 
Baseline body mass 
index (BMI) ≥ 30.0 76 25 60 
Laboratory 
values, % 
Hemoglobin 
A1c 
Baseline > 7.0% 
among people with 
diabetes 
58 49 69 
Serum 
creatinine Baseline ≥ 1.0 67 37 70 
Estimated 
glomerular 
filtration rate 
Baseline < 60 35 37 30 
 
a Veterans can fall into more than one ulcer etiology columns because 6 veterans had mixed arterial‐
venous ulcers and 3 veterans had mixed DFU‐arterial ulcer. 
 
Table 3. Chronic ulcer frequency and outcomes in VISN 20 veterans at 12 months follow‐up  
Ulcer frequency and 
outcomes at one year of 
follow‐up 
Venous ulcers 
N = 78a (47% had 
diabetes)  
Arterial ulcers 
N = 57a (70% had 
diabetes)  
DFU/neuropathic ulcers 
N = 98a (90% had diabetes)  
Healed n (%)  56 (72) 30 (53) 73 (75) 
Amputated n (%)  1 (1) 13 (23) 15 (15) 
Death n (%)  6 (8) 7 (12) 3 (3) 
Unresolved n (%)  14 (18) 6 (10) 7 (7) 
Loss to follow‐up n (%)  1 (1) 1 (2) 0 (0) 
• a Veterans can fall into more than one ulcer etiology columns because 6 veterans had 
mixed arterial‐venous ulcers and 3 veterans had mixed DFU‐arterial ulcer.  
 
Components of evidence‐based ulcer care and ulcer healing 
Among veterans with a venous ulcer, 20% had edema assessment or moist wound healing 
elements in at least 80% of their visits. However, sharp debridement was not performed on at 
least 80% of visits for any veteran with venous ulcer, thus this variable was excluded from 
further venous ulcer components of care analysis. There was a significantly higher chance of 
healing among veterans receiving edema assessment on at least 80% of visits (Hazard Ratio 
[HR] = 3.20, 95% Confidence Interval (95%CI): 1.34–7.66, p = 0.009) and infection assessment 
on at least 80% of visits (HR = 3.54, 95% CI 1.42–8.79, p = 0.006) (Table 4).  
Table 4. Chronic ulcer healing and evidence‐based ulcer care in VISN 20 veterans  
Ulcer etiology 
model 
Ulcer care 
component 
Percent veterans 
receiving treatment at 
specified thresholda 
Cox 
hazard 
ratio for 
healing 
95% 
confidence 
interval 
p 
value  
Venous (N = 78)b 
Edema assessment 
at ≥80% of visits 20 3.20 1.34−7.66 0.009 
Moist wound 
healing at ≥80% 
of visits 
20 0.50 0.18−1.42 0.192 
Infection 
assessment at 
≥80% of visits 
23 3.54 1.42−8.79 0.006 
Percent visits with 
edema treated 
when edema was 
present 
 1.00 0.99−1.01 0.907 
Ulcer etiology 
model 
Ulcer care 
component 
Percent veterans 
receiving treatment at 
specified thresholda 
Cox 
hazard 
ratio for 
healing 
95% 
confidence 
interval 
p 
value  
Sharp 
debridement at 
≥80% of visits 
0    
Arterial (N = 57)c 
Ischemia 
assessment at first 
visit 
56 1.40 0.57−3.28 0.489 
Encounter with 
vascular surgery 
within 30 days of 
ulcer onset 
39 1.91 0.73−5.0 0.191 
Infection 
assessment at 
≥80% of visits 
32 2.10 0.80−5.43 0.135 
DFU/Neuropathic 
(N = 98)d 
Debridement at 
≥80% of visits 19 2.50 1.1‐5.8 0.032      
Moist wound healing at 
≥80% of visits 19 0.65 0.28−1.5 0.329 
Offloading at ≥80% of visits 13 2.0 0.79−4.9 0.144 
Ischemia assessed at first 
visit 50 2.0 1.0−3.9 0.045 
Infection assessed at ≥80% 
of visits 51 0.80 0.41−1.6 0.509 
 
• Values in bold are statistically significant.  
• a Percent veterans with the specific ulcer etiology for whom listed component of ulcer 
care was achieved.  
• b Model also included: rural status; age at first study ulcer presentation; smoking status; 
and history of PAD, CAD, diabetes, lower limb ulcer, lower limb amputation, and 
moderate to severe renal disease.  
• c Model also included: rural status; age at first study ulcer presentation; smoking status; 
and history of CAD, diabetes, lower limb ulcer, lower limb amputation, and moderate to 
severe renal disease.  
• d Model also included: rural status; age at first study ulcer presentation; smoking status; 
and history of PAD, CAD, lower limb ulcer, lower limb amputation, and moderate to 
severe renal disease.  
• Among veterans with arterial ulcers, 32% had infection assessment in at least 80% of 
visits, 56% had ischemia assessment on the first visit, and 39% had a vascular surgery 
evaluation within 30 days of ulcer presentation. All arterial ulcer care HRs were above 1 
but not statistically significant (Table 4).  
• Among veterans with DFU/neuropathic ulcers, 19% had sharp debridement, 19% had 
moist wound healing, 50% had infection assessment, and 13% had offloading performed 
on at least 80% of visits. In addition, 50% were assessed for ischemia at first visit. The 
resultant likelihood of healing with sharp debridement was 2.5‐fold higher than in those 
not receiving sharp debridement at this frequency (95% CI: 1.10–5.80, p = 0.03). 
Ischemia assessment at the first visit doubled the likelihood of ulcer healing (HR=2.0, 
95% CI: 1.0–3.9, p = 0.045). Three remaining ulcer care components were not 
significantly associated with ulcer healing (Table 4).  
• Treatment of ulcer care components across all ulcer groups was similar between rural and 
urban settings (data not shown). The only component with significant impact on healing 
that was performed differently among rural and urban settings was edema assessment; 
35% of rural versus 11% of urban veterans received this component in at least 80% of 
visits (p = 0.016).  
DISCUSSION 
The major finding of this study is that components of EB ulcer care were not consistently 
performed for the majority of VISN 20 veterans with chronic LLU, regardless of ulcer etiology 
or rural and urban status. While EB ulcer care guidelines do not currently specify the frequencies 
for performing components of EB ulcer care, we set 80% of visits as a satisfactory threshold for 
ulcer care components based on the study by Olson and associates on venous ulcer healing. 
Unlike Olson and associates, we found that very few veterans received combination of all EB 
ulcer care components in at least 80% of their visits. Therefore, we were unable to analyze the 
impact of all EB ulcer components performed at this level. This may reflect the differences in 
setting and veteran populations between the two studies. The Olson and associates study 
involved primarily urban veterans receiving care at two multidisciplinary tertiary care centers 
while our study included veterans receiving ulcer care across VISN 20 rural and urban clinics.  
As hypothesized, among veterans with venous ulcers, we observed that both edema and infection 
assessment on at least 80% of visits significantly improved the chance of healing. We were 
unable to assess the association between debridement performance and healing as debridement of 
venous ulcers was done so infrequently. For DFU/neuropathic ulcers, sharp debridement had the 
greatest impact on healing when performed on at least 80% of visits. This was followed by 
ischemia assessment at first visit, thus emphasizing the importance of these two care components 
in the management of DFU/neuropathic ulcers. Other ulcer care components across the three 
ulcer types were not significantly associated with healing.  
In this study among venous ulcer patients, increasing the proportion of visits where edema was 
treated with compression therapy had no effect on venous ulcer healing (HR = 1.00, 95% CI: 
0.99–1.01, p = 0.680). Two reasons for this could be the lack of power to detect this relationship 
due to the sample size and poor patient compliance with compression therapy. A large study on 
patient compliance with prescribed compression therapy reported that 63% of patients with 
chronic venous disease did not use compression stockings or devices at all, 21% used them on a 
daily basis, and the rest used them inconsistently.35 
The VA recognizes the impact of chronic lower limb ulcers on function, quality of life, and 
healthcare cost. The VHA developed multidisciplinary programs such as High Risk Foot Clinics 
and Prevention of Amputation in Veterans Everywhere (PAVE) Program teams to prevent or 
delay amputations through proactive identification of patients at risk of limb loss. Our results 
suggest that improving guideline‐concordant care across all wound care settings, for example to 
a target of 80%, could improve wound outcomes.  
This study had several limitations. We defined debridement as sharp debridement which is 
considered the gold standard in wound care, thus excluding enzymatic and mechanical 
techniques.2, 3, 36 These additional means of debridement were included in Olson and 
associates and could explain why we did not see higher levels of debridement for venous ulcers. 
It is important to note that the group analyzed as DFU/neuropathic ulcers included six purely 
neuropathic ulcers in patients with no history of diabetes. Though there are no separate treatment 
guidelines for neuropathic ulcers, these ulcers may have different healing trajectories due to lack 
of diabetic pathology and therefore may have influenced the results obtained. Another study 
limitation was our inability to adjust for ulcer size and depth at the presentation due to frequent 
missing values. This could have confounded the relationship between EB ulcer care and 
healing.37 Our sample size may not have been large enough to detect association between some 
of the ulcer care components and healing.  
The study strengths included broad geographic diversity of ulcer patients. Studies show that rural 
veterans have reduced access to specialty providers, which could impact the quality of healthcare 
they receive.38 In our literature review we did not find chronic ulcer care studies that actively 
recruited rural patients. Our parent study population consists of 50% rural veterans to assess 
quality of ulcer care in both rural and urban settings.  
In summary, we found that evidence‐based ulcer care is not optimal for Pacific Northwest 
veterans. Our data indicate that the low frequency of guideline‐concordant care may be 
contributing to poor chronic lower limb ulcer outcomes. Therefore, providers of lower limb ulcer 
care need to address the components of ulcer care associated with improved ulcer outcomes, 
namely edema and infection assessment for venous ulcers and sharp debridement and ischemia 
assessment on first visit for DFU/neuropathic ulcers.  
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